Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

4051 - 4060 of 58470 results found

Complete biosynthesis of the potent vaccine adjuvant QS-21

Date
Friday, January 26, 2024 - 4:00 AM
Description
QS-21 is a potent vaccine adjuvant currently sourced by extraction from the Chilean soapbark tree. It is a key component of human vaccines for shingles, malaria, coronavirus disease 2019 and others under development. The structure of QS-21 consists

Genetic factors associated with long COVID

Date
Friday, January 26, 2024 - 4:00 AM
Description
CONCLUSIONS: Although studies on long-COVID are insufficient to fully comprehend the cause, it is clear that the current identified genetic factors do not fully explain the progression and onset of long-COVID. Other factors such as polygenic action

Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1

Date
Friday, January 26, 2024 - 4:00 AM
Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evades the innate immune machinery through multiple viral proteins, including nonstructural protein 1 (NSP1). While NSP1 is known to suppress translation of host mRNAs, the mechanisms